Services de lyophilisation pour le marché des produits biopharmaceutiques – Analyse des tendances et de la croissance | Année de prévision 2031

  • Report Code : TIPRE00009286
  • Category : Pharmaceuticals
  • Status : Published
  • No. of Pages : 156
Buy Now

[Rapport de recherche] Le marché des services de lyophilisation pour les produits biopharmaceutiques devrait passer de 2 051,41 millions de dollars américains en 2022 à 3 586,55 millions de dollars américains d’ici 2028 ; on estime qu'il enregistrera un TCAC de 9,9 % de 2023 à 2028.

La croissance du marché des services de lyophilisation pour les produits biopharmaceutiques est attribuée à la demande croissante de produits lyophilisés et à la croissance rapide des services de fabrication sous contrat et de lyophilisation à travers le monde. .

Le marché des services de lyophilisation pour les produits biopharmaceutiques est segmenté en fonction du type de service, de l'utilisateur final et de la région. Le rapport offre des informations et une analyse approfondie du marché, mettant l’accent sur des paramètres tels que les tendances du marché des services de lyophilisation pour les produits biopharmaceutiques, les progrès technologiques, la dynamique du marché et l’analyse du paysage concurrentiel des principaux acteurs du marché.   

Services de lyophilisation pour le marché des produits biopharmaceutiques - Aperçus stratégiques

Services de lyophilisation pour le marché des produits biopharmaceutiques mondiaux -

Services de lyophilisation pour le marché des produits biopharmaceutiques - Aperçus du marché     

L'augmentation rapide de la fabrication sous contrat et des services de lyophilisation stimule les services de lyophilisation pour la croissance du marché des produits biopharmaceutiques

Le marché des produits biopharmaceutiques continue de se développer à travers le monde, ce qui peut être le principal moteur de croissance de l’industrie pharmaceutique. La fabrication biopharmaceutique parentérale s'est développée récemment à mesure que davantage de produits biologiques thérapeutiques ont été approuvés. Les entreprises de biotechnologie sous-traitent à des organisations de fabrication sous contrat (OCM) pour répondre à leurs besoins de remplissage et de finition et réduire le risque de contamination microbienne. Les sociétés biopharmaceutiques dépendent des organisations de fabrication sous contrat (OCM) pour fournir les capacités et les capacités nécessaires ; dans certains cas, les CMO assurent une grande partie de la production d'une entreprise.

La mise en place de capacités et d'opérations de lyophilisation en interne nécessite un équipement et une expertise spécialisés, ce qui est coûteux et prend du temps. Cependant, l’externalisation coûte moins cher et augmente l’efficacité des processus de fabrication. De plus, cela permet aux entreprises de biotechnologie de rediriger leurs ressources vers d’autres domaines. Ainsi, les développeurs de médicaments et les sociétés biopharmaceutiques sous-traitent ces opérations à des sociétés de gestion collective afin de réduire les coûts globaux de production et de rendement. Il y a quelques années, l’industrie des CMO était un marché de services de niche, offrant des capacités de fabrication supplémentaires ou des services spécifiques aux entreprises de biotechnologie. Aujourd’hui, de nombreuses sociétés de biotechnologie externalisent divers services, depuis le développement précoce de médicaments jusqu’à la fabrication à l’échelle commerciale. Alors que l’industrie de la biotechnologie passe d’une production à grande échelle à des thérapies de niche et ciblées (médecine personnalisée), la demande de capacités opérationnelles flexibles, d’échelles de production et d’opérations multi-produits augmente. En raison de tous ces facteurs, la tendance à l’égard des CMO augmente. Jubilant HollisterStier Contract Manufacturing & Prestations de service. Le CMO propose un remplissage/finition stérile de la phase I grâce à un produit injectable stérile commercial et une suite complète de services de lyophilisation. Pour répondre à la demande croissante de ses services, Jubilant installe un nouveau lyophilisateur de 385 pieds carrés. Ainsi, la capacité et la disponibilité croissantes des CMO biopharmaceutiques alimentent les services de lyophilisation pour la croissance du marché des produits biopharmaceutiques.

Services mondiaux de lyophilisation pour le marché des produits biopharmaceutiques, par type de service - 2022 vs 2028

Services de lyophilisation pour le marché des produits biopharmaceutiques - Par informations basées sur le type de service

En fonction du type de service, le marché mondial des services de lyophilisation pour les produits biopharmaceutiques est segmenté en fabrication commerciale, développement de cycles de lyophilisation, fabrication clinique et services analytiques de lyophilisation. Le segment de la fabrication commerciale détenait la plus grande part de marché en 2022. Le segment de développement du cycle de lyophilisation devrait enregistrer le TCAC le plus élevé au cours de la période de prévision.

Services de lyophilisation pour le marché des produits biopharmaceutiques - Par informations basées sur l'utilisateur final

En fonction de l'utilisateur final, le marché mondial des services de lyophilisation pour les produits biopharmaceutiques est segmenté en sociétés pharmaceutiques et biotechnologiques, instituts de recherche et autres. Le segment des sociétés pharmaceutiques et biotechnologiques détenait la plus grande part de marché en 2022. Le segment des instituts de recherche devrait enregistrer le TCAC le plus élevé au cours de la période de prévision.

Les entreprises du marché des services de lyophilisation pour les produits biopharmaceutiques adoptent des produits inorganiques et biotechnologiques. stratégies organiques telles que les fusions et acquisitions. Quelques développements récents clés du marché sont répertoriés ci-dessous :

  • En novembre 2022, LTI a annoncé son engagement dans le développement, l'ingénierie des procédés et la préparation du matériel clinique pour le candidat vaccin contre la tuberculose ID93 / GLA-SE. . Le vaccin contre la tuberculose a atteint avec succès la phase 2 des essais cliniques. Cette étude représente le premier rapport sur la lyophilisation réussie d'un candidat vaccin sous-unitaire thermostable contenant un adjuvant à base d'émulsion.
  • En mai 2022, Jubilant HollisterStier LLC a conclu un accord de coopération d'un montant de 149,6 millions de dollars avec Army Contracting. Commandement, en coordination avec le Bureau exécutif du programme conjoint pour la défense chimique, biologique, radiologique et nucléaire (JPEOCBRND) au nom de la Biomedical Advanced Research and Development Authority (BARDA), au sein du ministère américain de la Santé et des Services sociaux.
  • En octobre 2021, PCI Pharma Services (PCI) a annoncé avoir signé un accord définitif pour acquérir Lyophilization Services de New England, Inc. (LSNE), une organisation de développement et de fabrication sous contrat (CDMO) de premier plan dont le siège est à Bedford. , New Hampshire, de la société mondiale de capital-investissement Permira. L'acquisition ajoute cinq installations approuvées par la FDA aux États-Unis (New Hampshire, Wisconsin) et en Europe (Espagne), et une sixième devrait être approuvée dans les mois à venir. De plus, trois installations supplémentaires sont en cours de développement. Ces installations renforceront leur réseau mondial de 30 sites.
  • En juillet 2021, Albany Molecular Research, Inc. (AMRI) a annoncé qu'elle changeait son nom pour Curia, à compter du 12 juillet 2021. Le nouveau nom renforce le positionnement stratégique de l'entreprise en tant que CDMO mondial de bout en bout, appliquant son expertise scientifique et ses capacités étendues de recherche et développement (R&D) à la fabrication commerciale pour permettre à ses clients pharmaceutiques et biotechnologiques de faire progresser de nouveaux produits importants qui améliorent des vies.     

Profils d'entreprises - Services de lyophilisation pour le marché des produits biopharmaceutiques

  • ATTWILL Medical Solutions
  • Axcellerate Pharma LLC
  • Labyrinth Biopharma LLC
  • Fabrication stérile Berkshire
  • PCI Pharma Services
  • Curia Global Inc
  • Emergent BioSolutions Inc
  • Jubilant HollisterStier LLC
  • Biofortuna
  • Lyophilization Technology Inc.
  • GROUPE SYNERLAB
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


Who are the key players in the lyophilization services for biopharmaceuticals market?

Companies operating in the market are ATTWILL Medical Solutions; Axcellerate Pharma LLC; Labyrinth Biopharma LLC; Berkshire Sterile Manufacturing; PCI Pharma Services; Curia Global Inc; Emergent BioSolutions Inc.; Jubilant HollisterStier LLC; Biofortuna; Lyophilization Technology Inc.; and SYNERLAB GROUP.

What is lyophilization?

Lyophilization is a process of isolating a solid substance from a solution. It is also known as freeze-drying is a process. The process is carried by freezing the solution and evaporating under vacuum. It helps in optimizing lyophilization cycle times and improves stability for critically complexes of injectable during the parenteral product development.

What is the regional market scenario of the lyophilization services for biopharmaceuticals market?

Global lyophilization services for biopharmaceuticals market is segmented by region into North America, Europe, Asia Pacific, the Middle East & Africa, and South & Central America. North America is likely to continue its dominance in the lyophilization services for biopharmaceuticals market during 2023–2028. The US holds the largest share of the market in North America and is expected to continue this trend during the forecast period.

What are the driving factors for the lyophilization services for biopharmaceuticals market across the globe?

The growth of market is likely to grow due to factors such as rising demand for lyophilized products and rapid growth in contract manufacturing and lyophilization services across the world are expected to boost the growth of the global lyophilization service for biopharmaceuticals market. However, the market is likely to get impacted by the demerits associated with lyophilization process during the forecast period.

Which segment led the lyophilization services for biopharmaceuticals market?

Based on service type, the global lyophilization services for biopharmaceuticals market is divided into commercial manufacturing, lyophilization cycle development, clinical manufacturing, and freeze-drying analytical services. The commercial manufacturing segment held the largest share of the market in 2022. The lyophilization cycle development segment is expected to grow at the highest CAGR during the forecast period.

Which end user segment held the largest revenue (US$ Mn) in the lyophilization services for biopharmaceuticals market?

Based on end user, the global lyophilization services for biopharmaceuticals market is divided into pharmaceutical and biotechnology companies, research institutes, and others. The pharmaceutical and biotechnology companies segment held the largest share of the market in 2022. The research institutes segment is expected to grow at the highest CAGR during the forecast period.

The List of Companies - Lyophilization Services for Biopharmaceuticals Market

  1. ATTWILL Medical Solutions
  2. Axcellerate Pharma LLC
  3. Labyrinth Biopharma LLC
  4. Berkshire Sterile Manufacturing
  5. PCI Pharma Services
  6. Curia Global Inc
  7. Emergent BioSolutions Inc
  8. Jubilant HollisterStier LLC
  9. Biofortuna 
  10. Lyophilization Technology Inc.
  11. SYNERLAB GROUP     

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports